EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, PLUR: Pluri Inc

03 Nov 25 15:49
LAST:

3.690

CHANGE:
 0.21		OPEN:
3.830		HIGH:
3.957		ASK:
0.000		VOLUME:
3.2K
CHG(%):
5.38		PREV:
3.900		LOW:
3.600		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
03 Nov 253.8303.9573.6003.6904.0K
31 Oct 253.9903.9903.7703.9007.5K
30 Oct 253.9104.0003.8603.89015.0K
29 Oct 253.9183.9183.6003.76010.2K
28 Oct 254.0704.0704.0004.0102.6K
27 Oct 254.0904.1003.8603.90012.2K
24 Oct 253.9103.9503.9003.9007.6K
23 Oct 253.8203.8903.6603.8806.2K
22 Oct 253.9804.0503.7003.86815.5K
21 Oct 254.0104.0904.0054.0905.7K

COMPANY PROFILE

Name:Pluri Inc
About:Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. It develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and immunotherapy platform. The company's product candidates include PLX-PAD, that is composed of maternal mesenchymal stromal cells originating from the placenta for the treatment of various indications, such as acute muscle injuries following hip fracture, acute respiratory distress syndrome due to coronavirus Disease (COVID-19), peripheral artery disease, intermittent claudication, and critical limb ischemia; PLX-R18, composed of fetal MSC like cells originating from the placenta for the treatment of hematopoietic complications of the H-ARS, and is in Phase I clinical trial to treat hematopoietic cell transplantation; and allogeneic MAIT cell therapy platform. It also offers cell manufacturing services and cell-based coffee; and develops and commercializes cultivated meat products. The company operates in the field of regenerative medicine, food tech, immunotherapy, CDMO, and AgTech. It has collaboration agreement with Bar-Ilan University to advance cancer immunotherapy for solid tumors. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.
Sector:Healthcare
Industry:Biotechnology
Address:MATAM Advanced Technology Park, Haifa, Israel, 3508409
Website:https://www.pluri-biotech.com
CIK:0001158780
ISIN:US72942G2030
FIGI:BBG000DQX509

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:3.854.3%
MA10:3.895.4%
MA20:4.1211.6%
MA50:4.5322.6%
MA100:4.7629.1%
MA200:4.6626.2%
RSI14:20.22 
WPR14:-100.00 
MTM14:-0.82
ROC14:-0.18 
ATR:0.23 
Week High:4.1011.1%
Week Low:3.602.5%
Month High:4.8531.4%
Month Low:3.6026.2%
Year High:7.1393.2%
Year Low:3.3310.8%
Volatility:29.22 

RECENT SPLITS

Date Ratio
01 Apr 20241-8
25 Jul 20191-10
26 Nov 20071-200